Clinical outcome of short-term compression after sclerotherapy for telangiectatic varicose veins.


Journal

Journal of vascular surgery. Venous and lymphatic disorders
ISSN: 2213-3348
Titre abrégé: J Vasc Surg Venous Lymphat Disord
Pays: United States
ID NLM: 101607771

Informations de publication

Date de publication:
03 2021
Historique:
received: 05 03 2020
accepted: 22 05 2020
pubmed: 6 6 2020
medline: 29 4 2021
entrez: 6 6 2020
Statut: ppublish

Résumé

Sclerotherapy is considered to be the method of choice for the treatment of telangiectatic varicose veins (C1 veins). Whereas the use of compression stockings after sclerotherapy is recommended, little is known about the impact of compression on the outcome of sclerotherapy. The aim of this study was to assess the influence of compression on the outcome of injection sclerotherapy of C1 varicose veins. There were 100 legs of 50 consecutive patients with chronic venous insufficiency (C1) included. After randomization per patient, both legs were treated with sclerotherapy in a predefined area of the thigh (measuring 100 cm There was no discernible difference between the groups in terms of clinical outcome or side effects after 4 weeks. Whereas inter-rater reliability was high, there was no correlation between the raters and patients in terms of outcome. In 55% of the treated legs, the patients deemed the result of the treatment to be good; in 27% of the treated legs, fair; and in 18%, poor. Postprocedure hyperpigmentation occurred in 13% of patients and was comparable in both groups. Compression therapy was found to be comfortable by the majority (58%) of patients. One week of postinterventional compression therapy had no clinical benefit compared with no compression.

Sections du résumé

BACKGROUND
Sclerotherapy is considered to be the method of choice for the treatment of telangiectatic varicose veins (C1 veins). Whereas the use of compression stockings after sclerotherapy is recommended, little is known about the impact of compression on the outcome of sclerotherapy. The aim of this study was to assess the influence of compression on the outcome of injection sclerotherapy of C1 varicose veins.
METHODS
There were 100 legs of 50 consecutive patients with chronic venous insufficiency (C1) included. After randomization per patient, both legs were treated with sclerotherapy in a predefined area of the thigh (measuring 100 cm
RESULTS
There was no discernible difference between the groups in terms of clinical outcome or side effects after 4 weeks. Whereas inter-rater reliability was high, there was no correlation between the raters and patients in terms of outcome. In 55% of the treated legs, the patients deemed the result of the treatment to be good; in 27% of the treated legs, fair; and in 18%, poor. Postprocedure hyperpigmentation occurred in 13% of patients and was comparable in both groups. Compression therapy was found to be comfortable by the majority (58%) of patients.
CONCLUSIONS
One week of postinterventional compression therapy had no clinical benefit compared with no compression.

Identifiants

pubmed: 32502730
pii: S2213-333X(20)30323-1
doi: 10.1016/j.jvsv.2020.05.015
pii:
doi:

Substances chimiques

Sclerosing Solutions 0
Polidocanol 0AWH8BFG9A

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

435-443

Informations de copyright

Copyright © 2020 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Andreas Bayer (A)

Department of Surgery, University Medical Centre Schleswig-Holstein, Campus Luebeck, Luebeck, Germany; Institute of Anatomy, Christian-Albrechts-University of Kiel, Kiel, Germany. Electronic address: a.bayer@anat.uni-kiel.de.

Nadine Kuznik (N)

Department of Dermatology, University Medical Centre Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.

Ewan Andrew Langan (EA)

Department of Dermatology, University Medical Centre Schleswig-Holstein, Campus Luebeck, Luebeck, Germany; Division of Musculoskeletal and Dermatological Sciences, University of Manchester, Manchester, United Kingdom.

Andreas Recke (A)

Department of Dermatology, University Medical Centre Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.

Anna-Lena Recke (AL)

Department of Dermatology, University Medical Centre Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.

Gabriele Faerber (G)

Center for Vascular Medicine, Hamburg, Germany.

Mark Kaschwich (M)

Department of Surgery, University Medical Centre Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.

Markus Kleemann (M)

Department of Surgery, University Medical Centre Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.

Birgit Kahle (B)

Department of Dermatology, University Medical Centre Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH